Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and B-Cell Chronic Lymphocytic Leukemia

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ryan, EP1
Pollock, SJ1
Kaur, K1
Felgar, RE1
Bernstein, SH1
Chiorazzi, N1
Phipps, RP1
Bellosillo, B1
Piqué, M1
Barragán, M1
Castaño, E1
Villamor, N1
Colomer, D1
Montserrat, E1
Pons, G1
Gil, J1

Other Studies

2 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Constitutive and activation-inducible cyclooxygenase-2 expression enhances survival of chronic lymphocytic leukemia B cells.
    Clinical immunology (Orlando, Fla.), 2006, Volume: 120, Issue:1

    Topics: B-Lymphocytes; Cell Growth Processes; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitor

2006
Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells.
    Blood, 1998, Aug-15, Volume: 92, Issue:4

    Topics: Aged; Amino Acid Chloromethyl Ketones; Annexins; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis;

1998